Increasing evidence indicates that in cancer, Impad1 acted in the ER-Golgi pathway by altering Golgi-mediated secretion of MMPs, resulting in a pro-invasive and metastatic tumour phenotype [36]. The gene discussed is BPNT2; the disease is neoplasm.